The value of investments and any income from them may go down as well as up and you or your client may not get back the amount originally invested.
The Trust aims to maximise capital growth over the long-term from investment primarily in shares of listed UK equities which have the potential to deliver a total return in excess of the FTSE All-Share Index.
About the Trust
The Trust’s portfolio is constructed without any reference to the index and will not replicate it. The majority of the portfolio will be held in listed UK equities and may, if appropriate, include convertible securities and equity related derivatives. The yield on the Trust’s investments is of secondary importance.
Meet the Trust ManagersIain McCombie
Iain graduated MA in Accounting from Aberdeen University and trained as a Chartered Accountant. He joined Baillie Gifford in 1994, and spent five years training as an Investment Manager in the US Equities Team before joining the UK Equity Team in 1999. Iain became a partner of the firm in 2005 and served as Chief of Investment Staff from 2013 to 2018. He is the lead manager of our UK Core strategy, and Head of the Pan-European and a member of the Global Stewardship Portfolio Construction Groups (PCGs).Milena Mileva
Milena completed her MPhil in Politics at Oxford University in 2009, having graduated with a BA in Social & Political Science from the University of Cambridge in 2007. She joined Baillie Gifford in 2009 and is an Investment Manager in the UK Equity Team. Milena co-manages the Trust.
Actual investors imagine 'what if?'
Not 'what is'.
Meet our DirectorsCarolan Dobson - Chairman
Carolan was appointed a Director on 13 March 2014 and became Chairman in 2016. She is also Chairman of the Nomination Committee and Management Engagement Committee. She is Chairman of Brunner Investment Trust plc and Blackrock Latin American Investment Trust plc. She was a fund manager holding a number of positions including Director at Murray Johnstone Ltd and subsequently undertook several key roles at Abbey Asset Managers Ltd.Andrew Westenberger - Director
Andrew was appointed a Director on 5 May 2017 and became Chairman of the Audit Committee in August 2017. He is Chief Financial Officer of Integro Insurance Brokers and Tysers, a leading independent specialist broker and risk management firm. He is also a non-executive director and trustee of the Chartered Institute of Securities and Investments. Previously, he was Group Finance Director of Brewin Dolphin Holdings PLC and Evolution Group Plc and held senior finance roles at Barclays Capital and Deutsche Bank. He is a Chartered Accountant.Scott Cochrane - Director
Scott was appointed a Director on 15 November 2018 and became Senior Independent Director on 1 August 2019. He is also Chairman of the Remuneration Committee. He is Global Head of Corporate International law firm Herbert Smith Freehills where he is responsible for leading the strategic direction of the practice across a global network of offices. He is also a member of the firm’s Global Executive and has over 25 years' experience advising clients in the asset management sector on a broad range of corporate matters.Ruary Neill - Director
Ruary was appointed a Director on 15 November 2018. He is currently a director of JP Morgan Emerging Markets Investment Trust plc, chairs the Investment Committee at Great Ormond Street Children’s Charity and is a member of the Advisory Board, SOAS China Institute, London University. Previously, he worked in investment banking at UBS Investment Bank prior to which he spent several years in the financial sector working in Asian Equity Markets for UBS Investment Bank and Schroder Securities.
The portfolio is a high conviction, concentrated selection of our best ideas in the UK with a bias to mid and smaller cap growth companies, where we intuitively believe the growth spot for UK equities to be.
The principal investment objective of the Company is to achieve capital growth predominantly from investment in UK equities, with the aim of providing a total return in excess of the FTSE All-Share Index.
The Company invests in a relatively concentrated portfolio of between 35 and 65 stocks principally selected for their potential to provide shareholders with attractive returns relative to the FTSE All-Share Index. The portfolio is invested primarily in listed UK equities. It may, if appropriate, include convertible securities, and equity-related derivatives may be used for efficient portfolio management purposes. The yield on the Company’s investment portfolio is of secondary importance.
The stocks are predominantly constituents of the FTSE 350 Index.
The size of individual stock holdings depends on the Manager’s degree of conviction, not the stock’s weight in any index.